CADTH Canadian Drug Expert Committee recommendation : indication: systemic lupus erythematosus (SLE)Belimumab (Benlysta subcutaneous [SC] -- GlaxoSmithKline Inc.)

Medienart:

E-Book

Erscheinungsjahr:

April 2020

Erschienen:

Ottawa (ON): CADTH ; April 2020

Reihe:

CADTH common drug review

Sprache:

Englisch

Links:

www.ncbi.nlm.nih.gov [teilw. kostenfrei]

Themen:

Antibodies, Monoclonal, Humanized
Canada
Cost-Benefit Analysis
Immunosuppressive Agents
Insurance, Health, Reimbursement
Lupus Erythematosus, Systemic

Anmerkungen:

Description based on online resource; title from PDF title page (viewed March 15, 2021)

Umfang:

1 online resource (1 PDF file (8 pages)).

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

1773183230